Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DAROLUTAMIDE vs DATOPOTAMAB DERUXTECAN-DLNK: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DAROLUTAMIDE vs DATOPOTAMAB DERUXTECAN-DLNK: Safety Overview

Metric DAROLUTAMIDE DATOPOTAMAB DERUXTECAN-DLNK
Total FAERS Reports 3,247 165
Deaths Reported 508 36
Death Rate 15.6% 21.8%
Hospitalizations 723 33
Average Patient Age 73.6 yrs 61.4 yrs
% Female Patients 0.4% 89.2%
FDA Approval Date Jul 30, 2019 N/A
Manufacturer Bayer HealthCare Pharmaceuticals Inc. N/A
Route ORAL N/A
Marketing Status Prescription Prescription